A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation

Clinica Chimica Acta

Volumn 371, Issue 1-2, 2006, Pages 124-129

  Willemse, Johan L ^a   Hendriks, Dirk F ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Anaphylatoxin inactivator; Carboxypeptidase N; Inflammation; Kinetic assay

Indexed keywords

ARGININE CARBOXYPEPTIDASE; BENZOYLALANYLARGININE; BENZOYLGLYCYLARGININE; ENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD SAMPLING; CELL INFILTRATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; INFLAMMATION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; ANAPHYLATOXINS; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPEPTIDES; HUMANS; INFLAMMATION; KINETICS; LYSINE CARBOXYPEPTIDASE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33746848109     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.02.035     Document Type: Article

References (18)

1. Erdos E.G., and Sloane E.M. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem Pharmacol 11 (1962) 562-585
2. Mathews K., Mueller-Ortiz S., and Wetsel R. Carboxypeptidase N: a pleiotropic regulator of inflammation. Mol Immunol 40 (2004) 785-793
3. Bokisch V.A., and Müller-Eberhard H.J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest 49 (1970) 2427-2436
4. Mathews K.P., Pan P.M., Gardner N.J., and Hughli T.E. Familial carboxypeptidase N deficiency. Ann Int Med 93 (1980) 443-445
5. Mathews K.P., Curd J.G., and Hughli T.E. Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency. J Clin Immunol 6 (1986) 87-91
6. Cao H., and Hegele R.A. DNA polymorphism and mutations in CPN1, including the genomic basis of carboxypeptidase N deficiency. J Hum Genet 48 (2003) 20-22
7. Davis D.A., Singer K.E., De La Luz Sierra M., et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell derived factor-1 alpha in the circulation. Blood 105 (2005) 4561-4568
8. Wang W., Hendriks D.F., and Scharpé S.S. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 269 (1994) 15937-15944
9. Willemse J., Leurs J., Verkerk R., and Hendriks D. Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate. Anal Biochem 340 (2005) 106-112
10. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-258
11. Hendriks D., Scharpé S., and van Sande M. Assay of carboxypeptidase N activity in serum by liquid chromatographic detection of hippuric acid. Clin Chem 12 (1985) 1936-1939
12. Hendriks D., Van Sande M., and Scharpé S. Colorimetric assay for carboxypeptidase N in serum. Clin Chim Acta 157 (1986) 103-108
13. Willemse J.L., Leurs J.R., and Hendriks D.F. Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma. J Thromb Haemost 3 (2005) 2353-2355
14. Willemse J., and Hendriks D. Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge. Clin Chem 52 (2006) 30-36
15. Hendriks D., Scharpé S., van Sande M., and Lommaert M.P. A labile enzyme in fresh human serum interferes with the assay of carboxypeptidase N. Clin Chem 35 (1989) 177
16. Hendriks D., and Willemse J. The discovery of TAFI. J Thromb Haemost 4 (2006) 261-262
17. Boffa M.B., Wang W., Bajzar L., and Nesheim M.E. Plasma and recombinant thrombin activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin dependent activation, thermal stability and enzymatic properties. J Biol Chem 273 (1998) 2127-2135
18. Schneider M., Boffa M., Stewart R., Rahman M., Koschinsky M., and Nesheim M. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. J Biol Chem 277 (2002) 1021-1030